Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Romain Lambert
Observed name:
R. Lambert
Institution:
DBV Technologies (France)
Observed institutions:
DBV Technologies (France),
University of Southampton
OpenAlex ID:
A5025879418
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial
2019
·
David M. Fleischer
, Matthew Greenhawt
, et al.
·
JAMA
·
289
PDF
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
2020
·
David M. Fleischer
, Wayne G. Shreffler
, et al.
·
Journal of Allergy and Clinical Immunology
·
102
PDF
Evidence that eating baked egg or milk influences egg or milk allergy resolution: a systematic review
2017
·
R. Lambert
, K. E. C. Grimshaw
, et al.
·
Clinical & Experimental Allergy
·
87
Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergy
2020
·
David M. Fleischer
, Jonathan M. Spergel
, et al.
·
Allergy and Asthma Proceedings
·
10
Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities
2022
·
Carla M. Davis
, Lars Lange
, et al.
·
Journal of Allergy and Clinical Immunology Global
·
9
PDF
Improvements in eliciting dose across baseline sensitivities following 12 months of epicutaneous immunotherapy (EPIT) in peanut-allergic children aged 4 to 11 years
2020
·
Matthew Greenhawt
, Edwin H. Kim
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
8
Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy
2021
·
Philippe Bégin
, John Andrew Bird
, et al.
·
Allergy
·
6
P300 Evaluation of Daily Patch Application Duration for Epicutaneous Immunotherapy for Peanut Allergy
2020
·
J. Spergel
, D. Fleischer
, et al.
·
Annals of Allergy Asthma & Immunology
Efficacy and Safety of Epicutaneous Immunotherapy for Peanut Allergy in Subjects With and Without Atopic Dermatitis
2019
·
Carla M. Davis
, Todd David Green
, et al.
·
Journal of Allergy and Clinical Immunology
PDF
Serum Biomarkers of Immunomodulation During Peanut Epicutaneous Immunotherapy (epit) in Peanut-allergic Subjects
2018
·
M. Greenhawt
, W. Carr
, et al.
·
Annals of Allergy Asthma & Immunology
Increased Reactivity Threshold in Peanut-allergic Subjects Treated With 12 Months of Epicutaneous Viaskin Peanut
2018
·
T. Green
, C. Davis
, et al.
·
Annals of Allergy Asthma & Immunology
Show more works
View as search
Works count:
11
Citation count:
511
H-index:
6
I10-index:
4
Year
Topic
Type